Roadman Investments to buy CBP

Canadian venture capital firm Roadman Investments has agreed to acquire CLOV Biopharma Corp.

14 February 2020•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.